Roslin Technologies

Roslin Technologies is a Scottish biotechnology company established as a joint venture between the University of Edinburgh and two impact-focused investment partners. It was formed to commercialize research from the Roslin Institute and the Royal School of Veterinary Studies. The company specializes in animal stem cells, focusing on the production of primary cells and induced pluripotent stem (iPS) cells from farm animals for both academic research and farmed meat production. In addition to its work with the Roslin Institute, the company works closely with other academic and commercial organizations to advance its offerings and mission. In October 2022, the company achieved a breakthrough in scaling up the production of cultured pork, resulting in a 61% reduction in production costs.

Funding and Financials

In its latest funding round, in November 2022, the company raised GBP 11 million (~USD 12 million) in a Series A funding round led by Novo Holdings. The funding was expected to support the company expand its cell-line portfolio and further develop protocols for scaling up cells into cost-effective cell biomass for meat production.